UW researcher using stem cells to create ‘spare part’ for blindness

To mark the 20th anniversary of the stem cell discovery at UW-Madison, the Wisconsin State Journal featured a series of stories on stem cell research, highlighting the work of Waisman Center investigators David Gamm, Anita Bhattacharyya, Su-Chun Zhang, affiliate Randall Ashton, as well as Waisman Biomanufacturing.

Researchers at the Waisman Center use stem cells— undifferentiated “master cells” with the ability to become any of the body’s cell types –for translational research focused on neurodegenerative diseases and developmental disabilities.

To read about Gamm’s work developing stem cell-based therapies for diseases of the eye, click here.

To read about the stem cell research happening at the Waisman Center and UW-Madison, click here:

To read about several stem cell companies established by Waisman researchers, click here

To read about Waisman Biomanufacturing’s role in a stem cell-based clinical trial, click here:


Image caption and credit:

Dr. David Gamm examines the eyes of Gavina Zimbric, 11, of Waterloo, at UW Health’s University Station Clinic. Gamm, a pediatric ophthalmologist, is using stem cells to try to develop cell therapies for blinding disorders. He’s one of about 100 faculty researchers at UW-Madison studying stem cells, 20 years after campus scientist James Thomson announced he first grew human embryonic stem cells in the lab. Gamm performed surgery on Gavina, who had strabismus, or crossed eyes.